Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)

NCT07542041 is registered in ClinicalTrials.gov with ARTIDIS AG as lead sponsor.

NCT NCT07542041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)
Lead sponsor
ARTIDIS AG
Phase
Not applicable
Overall status
Recruiting
Start date
April 17, 2026
Completion date
May 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, pancreatic ductal adenocarcinoma (pdac), pancreatic lesions located at the body or the tail, pancreatic neoplasms